Artículos por temáticas

The clinical meaning of levodopa equivalent daily dose in Parkinson's disease

Julien C, Hache G, Dulac M, Dubrou C, Castelnovo G, Giordana C, Azulay JP, Fluchère F.

Fundam Clin Pharmacol. 2021 Jun;35(3):620-630. doi: 10.1111/fcp.12646. Epub 2021 Feb 23.

Quantifying upper limb motor impairment in people with Parkinson's disease: a physiological profiling approach

Ingram LA, Carroll VK, Butler AA, Brodie MA, Gandevia SC, Lord SR.

PeerJ. 2021 Feb 5;9:e10735. doi: 10.7717/peerj.10735. eCollection 2021.

An artificial neural network approach to detect presence and severity of Parkinson's disease via gait parameters

Varrecchia T, Castiglia SF, Ranavolo A, Conte C, Tatarelli A, Coppola G, Di Lorenzo C, Draicchio F, Pierelli F, Serrao M.

PLoS One. 2021 Feb 19;16(2):e0244396. doi: 10.1371/journal.pone.0244396. eCollection 2021.

Extra-striatal dopamine in Parkinson's disease with rapid eye movement sleep behavior disorder

Valli M, Cho SS, Masellis M, Chen R, Koshimori Y, Diez-Cirarda M, Mihaescu A, Christopher L, Strafella AP.

J Neurosci Res. 2021 Apr;99(4):1177-1187. doi: 10.1002/jnr.24779. Epub 2021 Jan 20.

SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease

Gómez-López A, Sánchez-Sánchez A, Natera-Villalba E, Ros-Castelló V, Beltrán-Corbellini Á, Fanjul-Arbós S, Pareés Moreno I, López-Sendon Moreno JL, Martínez Castrillo JC, Alonso-Canovas A.

Brain Sci. 2021 Jan 6;11(1):57. doi: 10.3390/brainsci11010057.

Make a Left Turn: Cortico-Striatal Circuitry Mediating the Attentional Control of Complex Movements

Sarter M, Avila C, Kucinski A, Donovan E.

Mov Disord. 2021 Mar;36(3):535-546. doi: 10.1002/mds.28532. Epub 2021 Feb 22.

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease

Marsal-García L, Urbizu A, Arnaldo L, Campdelacreu J, Vilas D, Ispierto L, Gascón-Bayarri J, Reñé R, Álvarez R, Beyer K.

Int J Mol Sci. 2021 Jan 13;22(2):725. doi: 10.3390/ijms22020725.

A Comprehensive Meta-analysis on Short-term and Working Memory Dysfunction in Parkinson's Disease

Ramos AA, Machado L.

Neuropsychol Rev. 2021 Jun;31(2):288-311. doi: 10.1007/s11065-021-09480-w. Epub 2021 Feb 1.

Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease

Heckman MG, Labbé C, Kolicheski AL, Soto-Beasley AI, Walton RL, Valentino RR, Brennan ER, Johnson PW, Baheti S, Sarangi V, Ren Y, Uitti RJ, Wszolek ZK, Ross OA.

Parkinsonism Relat Disord. 2021 Jan 11;83:22-30. doi: 10.1016/j.parkreldis.2020.12.016. Online ahead of print.

The neural correlates of gait improvement by rhythmic sound stimulation in adults with Parkinson's disease - A functional magnetic resonance imaging study

Nishida D, Mizuno K, Yamada E, Hanakawa T, Liu M, Tsuji T.

Parkinsonism Relat Disord. 2021 Mar;84:91-97. doi: 10.1016/j.parkreldis.2021.02.010. Epub 2021 Feb 11.

CD33 rs3865444 as a risk factor for Parkinson's disease

Siokas V, Arseniou S, Aloizou AM, Tsouris Z, Liampas I, Sgantzos M, Liakos P, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E.

Neurosci Lett. 2021 Mar 23;748:135709. doi: 10.1016/j.neulet.2021.135709. Epub 2021 Feb 11.

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease

Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, Hertzberg V, Auvinen P, Tansey MG, Scheperjans F.

Mol Neurodegener. 2021 Feb 8;16(1):6. doi: 10.1186/s13024-021-00427-6.

Mini Review: Correlations of Cognitive Domains With Cerebrospinal Fluid α-Synuclein Levels in Patients With Parkinson's Disease

Murakami H, Ono K, Shiraishi T, Umehara T, Omoto S, Iguchi Y.

Front Aging Neurosci. 2021 Jan 21;12:616357. doi: 10.3389/fnagi.2020.616357. eCollection 2020.

Parkinson's Patients' Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique Study

Hauber B, Mange B, Zhou M, Chaudhuri S, Benz HL, Caldwell B, Ruiz JP, Saha A, Ho M, Christopher S, Bardot D, Sheehan M, Donnelly A, McLaughlin L, Gwinn K, Lo A, Sheldon M.

MDM Policy Pract. 2021 Jan 18;6(1):2381468320978407. doi: 10.1177/2381468320978407. eCollection 2021 Jan-Jun.

Art therapy for Parkinson's disease

Cucca A, Di Rocco A, Acosta I, Beheshti M, Berberian M, Bertisch HC, Droby A, Ettinger T, Hudson TE, Inglese M, Jung YJ, Mania DF, Quartarone A, Rizzo JR, Sharma K, Feigin A, Biagioni MC, Ghilardi MF.

Parkinsonism Relat Disord. 2021 Mar;84:148-154. doi: 10.1016/j.parkreldis.2021.01.013. Epub 2021 Jan 23.